JDHIF (JD Health International) EPS without NRI: $0.24 (TTM As of Dec. 2025)


JDHIF JD Health International Inc JDHIF
90 GF Score
Price $5.85
GF Value $10.42
! 1 Warning Sign
View Full Analysis

What is JD Health International EPS without NRI?

JD Health International JDHIF 90 EPS without NRI is $0.24 as of Dec. 2025. GuruFocus rates JDHIF with a GF Score™ of 90/100 and a GF Value™ of $10.42. The stock has 1 warning sign investors should review. Among 511 Healthcare Providers & Services companies, JD Health International ranks better than 98.43% on this metric.

JD Health International's earnings per share without non-recurring items for the six months ended in Dec. 2025 was $0.13. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $0.24.

During the past 12 months, JD Health International's average earnings per share (NRI) Growth Rate was 26.50% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 128.10% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for JD Health International's EPS without NRI or its related term are showing as below:

JDHIF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 128.1   Med: 128.1   Max: 128.1
Current: 128.1

During the past 9 years, JD Health International's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 128.10% per year. The lowest was 128.10% per year. And the median was 128.10% per year.

JDHIF's 3-Year EPS without NRI Growth Rate is ranked better than
98.43% of 511 companies
in the Healthcare Providers & Services industry
Industry Median: 11.3 vs JDHIF: 128.10

JD Health International's EPS (Diluted) for the six months ended in Dec. 2025 was $0.12. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.24.

JD Health International's EPS (Basic) for the six months ended in Dec. 2025 was $0.14. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.25.


JD Health International  (OTCPK:JDHIF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


JD Health International EPS without NRI Related Terms


JD Health International EPS without NRI Historical Data

* Premium members only.

The historical data trend for JD Health International's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JD Health International EPS without NRI Chart

JD Health International Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only -0.05 0.02 0.10 0.19 0.24

JD Health International Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.09 0.11 0.12 0.13

JD Health International EPS without NRI Competitor Comparison

For the Pharmaceutical Retailers subindustry, JD Health International's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JD Health International PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where JD Health International's PE Ratio without NRI falls into.


JDHIF
90GF Score
JD Health International Inc JDHIF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JD Health International EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.24 mean?
JD Health International (JDHIF) has a EPS without NRI of $0.24 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on JD Health International and its competitors. According to the industry distribution chart, JD Health International ranks #8 out of 511 companies in the Healthcare Providers & Services industry, placing it in the top 1.6%.
Is JD Health International's EPS without NRI too high?
JD Health International's current EPS without NRI is $0.24. The Healthcare Providers & Services industry median EPS without NRI is 11.30. JD Health International's value of $0.24 is 97.9% below this industry median. Based on the distribution chart, JD Health International ranks #8 out of 511 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, JD Health International has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does JD Health International's EPS without NRI compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #8 out of 511 companies for EPS without NRI. This places JD Health International in the top 2% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 11.30. JD Health International's value of $0.24 is 97.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.30, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current EPS without NRI of $0.24 is 97.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on JD Health International and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current EPS without NRI is $0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
JD Health International (JDHIF) has a current EPS without NRI of $0.24. The stock's GF Value™ is $10.42, compared to a current price of $5.85 — trading 43.9% below its estimated fair value. The current EPS without NRI is $0.24 and 97.9% below the Healthcare Providers & Services industry median of 11.30. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For JD Health International (JDHIF), the current EPS without NRI is $0.24 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JD Health International (JDHIF) Overvalued in 2026?

Based on GuruFocus' analysis, JD Health International stock appears to be undervalued. The current stock price of $5.85 is trading 43.9% below its estimated GF Value™ of $10.42.

Key valuation signals for JDHIF:

  • EPS without NRI: $0.24
  • GF Value™: $10.42 vs. price of $5.85 (43.9% below fair value)
  • GF Score™: 90/100 with 1 warning sign
  • Industry Position: 97.9% below the Healthcare Providers & Services median (#8 of 511)

No single metric tells the full story. See the JDHIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JD Health International Business Description

Address No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score

Get the complete analysis for JDHIF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.85
Price
$10.42
GF Value